Craft

Organigram

Stock Price

$2.8

2024-02-26

Market Capitalization

$258.8 M

2024-02-26

Revenue

$161.6 M

FY, 2023

Organigram Summary

Company Summary

Overview
Organigram is a producer of medical cannabis and cannabis-derived products. The company offers indoor-grown cannabis for patients and adult recreational consumers. Its portfolio of legal adult use recreational cannabis brands includes Edison Cannabis, ANKR Organics, and Trailblazer.
Type
Public
Status
Active
Founded
2013
Website
https://www.organigram.ca/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Gregory Engel

    Gregory Engel, Chief Executive Officer, Director

  • Amy Schwalm

    Amy Schwalm, Vice President, Investor Relations

  • Paolo de Luca

    Paolo de Luca, Chief Strategy Officer

  • Tim Emberg

    Tim Emberg, Senior Vice President, Sales and Commercial Operations

Operating MetricsView all

Patients

18.1K
34.2%

Q1, 2020

Brands

3
40.0%

Q1, 2020

Average Selling Price per Gram (Dried Cannabis)

$C4.6

Q1, 2020

Organigram Financials

Summary Financials

Revenue (FY, 2023)
$C161.6M
Gross profit (FY, 2023)
$C25.2M
Net income (FY, 2023)
($C248.6M)
Cash (FY, 2023)
$C33.9M
EBIT (FY, 2023)
($C260.5M)
Enterprise value
$217.1M

Footer menu